Skip Navigation
Menu
ACP Journal Club |19 August 2008

Risk for cancer was still increased over 2 years after stopping hormone therapy

Angela M. Cheung, MD, PhD

Article, Author, and Disclosure Information
FULL TEXT
Heiss G, Wallace R, Anderson GL, et al. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA. 2008;299:1036-45. 18319414

GIM/FP/GP:

Cardiology:

Endocrinology:

After release of the initial results of the WHI trial, which showed that hormone therapy (HT) increased risks for CV and thromboembolic events and invasive breast cancer (1), many postmenopausal women discontinued HT. In 2003, Ravdin and colleagues (2) described a decline in breast cancer incidence coinciding with decreased HT prescriptions; however, Heiss and colleagues found that cancer risk increased after stopping HT. More diagnoses of breast cancer were made in...
FULL TEXT
PDF
Not Available
Citations
Citation

Cheung AM. Risk for cancer was still increased over 2 years after stopping hormone therapy. Ann Intern Med. 2008;149:JC2–11. doi: 10.7326/0003-4819-149-4-200808190-02011

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2008;149(4):JC2-11.

DOI: 10.7326/0003-4819-149-4-200808190-02011

0 Citations

Related Articles
Should This Patient Receive Hormone Therapy for Her Menopausal Symptoms?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Annals of Internal Medicine; 168 (3): 203-209
Pooled RCTs: In postmenopausal women, hormone therapy for 6 to 7 years did not affect mortality at 18 years
Annals of Internal Medicine; 168 (2): JC4
Annals for Educators - 15 August 2017
Annals of Internal Medicine; 167 (4): ED4
Update in Women's Health: Evidence Published in 2012
Annals of Internal Medicine; 159 (3): 203-209
View MoreView Less

Journal Club
Pooled RCTs: In postmenopausal women, hormone therapy for 6 to 7 years did not affect mortality at 18 years
Annals of Internal Medicine; 168 (2): JC4
Hormone therapy increased risk for kidney stones in healthy postmenopausal women
Annals of Internal Medicine; 154 (6): JC3-10
Review: Hormone therapy reduces mortality in younger postmenopausal women
Annals of Internal Medicine; 152 (8): JC4-9
Risk for breast cancer declined after postmenopausal hormone therapy was stopped
Annals of Internal Medicine; 150 (12): JC6-11
View MoreView Less

Related Point of Care
Menopause
Annals of Internal Medicine; 150 (7): ITC4-1
View MoreView Less

Related Topics
Cancer Screening/Prevention
Hematology/Oncology
Prevention/Screening

Cancer Screening/Prevention, Hematology/Oncology, Prevention/Screening.

PubMed Articles
Development of New Biokinetic-Dosimetric Models for the Simulation of Iodine Blockade in the Case of Radioiodine Exposure in Man.
Drug Res (Stuttg) 2019.
Pulmonary Embolism and Gas Exchange.
Respiration 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×